CoChat

Inflammation across the spectrum of hypertrophic cardiac phenotypes

Open access
Lillo, Rosa, Graziani, Francesca, Franceschi, Francesco, Iannaccone, Giulia, Massetti, Massimo, Olivotto, Iacopo, Crea, Filippo, Liuzzo, Giovanna · 2023 · Heart Failure Reviews
Cited by 62

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The hypertrophic cardiomyopathy phenotype encompasses a heterogeneous spectrum of genetic and acquired diseases characterized by the presence of left ventricular hypertrophy in the absence of abnormal cardiac loading conditions. This “umbrella diagnosis” includes the “classic” hypertrophic cardiomyopathy (HCM), due to sarcomere protein gene mutations, and its phenocopies caused by intra‐ or extracellular deposits, such as Fabry disease (FD) and cardiac amyloidosis (CA). All these conditions share a wide phenotypic variability which results from the combination of genetic and environmental factors and whose pathogenic mediators are poorly understood so far. Accumulating evidence suggests that inflammation plays a critical role in a broad spectrum of cardiovascular conditions, including cardiomyopathies. Indeed, inflammation can trigger molecular pathways which contribute to cardiomyocyte hypertrophy and dysfunction, extracellular matrix accumulation, and microvascular dysfunction. Growing evidence suggests that systemic inflammation is a possible key pathophysiologic process potentially involved in the pathogenesis of cardiac disease progression, influencing the severity of the phenotype and clinical outcome, including heart failure. In this review, we summarize current knowledge regarding the prevalence, clinical significance, and potential therapeutic implications of inflammation in HCM and two of its most important phenocopies, FD and CA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10741-023-10307-4

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Inflammatory profiling of patients with familial amyloid polyneuropathy

    Azevedo, E. P., Guimaraes-Costa, A. B., Bandeira-Melo, C., Chimelli, L., Waddington-Cruz, M., Saraiva, E. M., Palhano, F. L., & Foguel, D. (2019) · BMC Neurology · doi:10.1186/s12883-019-1369-4 · Cited by 66 · cited 4×

    “[75] found that asymptomatic patients with familial amyloid polyneuropathy (FAP) present high levels of IL-33, IL-1β, and IL-10, suggesting that inflammation has a role in the early stages of the disease.”
    BackgroundResultInfluential

Show all 1 references

Cited by

See all 62

Metadata

Authors
Lillo, R., Graziani, F., Franceschi, F., Iannaccone, G., Massetti, M., Olivotto, I., Crea, F., & Liuzzo, G.
Venue
Heart Failure Reviews
Published
2023-04-28
Volume
28
Issue
5
Pages
1065-1075
ISSN
  • 1382-4147 (ISSN-L)
  • 1573-7322
OpenAlex
W4367299966
Cited by
62
References
1
FWCI
10.91
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation across the spectrum of hypertrophic cardiac phenotypes. https://app.cochat.ai/papers/10.1007/s10741-023-10307-4
The paper
Lillo, R., Graziani, F., Franceschi, F., Iannaccone, G., Massetti, M., Olivotto, I., Crea, F., & Liuzzo, G. (2023). Inflammation across the spectrum of hypertrophic cardiac phenotypes. Heart Failure Reviews. https://doi.org/10.1007/s10741-023-10307-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.